• 1
    Delaney BC, Moayyedi P, Deeks J, et al. The management of dyspepsia: a systematic review. Health Technol Assess 2000; 4: 1189.
  • 2
    Talley NJ. Dyspepsia: management guidelines for the millennium. Gut 2002; 50: 72iv8.
  • 3
    Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preference for health states. Oper Res 1982; 30: 104369.
  • 4
    Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998; 316: 73641.
  • 5
    Fraser A, Delaney B, Moayyedi P. Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review. Am J Gastroenterol 2005; 100: 44252.
    Direct Link:
  • 6
    Agreus L. Natural history of dyspepsia. Gut 2002; 50: 2iv9.
  • 7
    Sharma N, Donnellan C, Preston C, Delaney B, Duckett G, Moayyedi P. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials. Gut 2004; 53 (Suppl. 4): iv5865.
  • 8
    Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 117483.
  • 9
    McColl E. Best Practice in Symptom Assessment: a review. Gut 2004; 53 (Suppl. 4): iv4954.
  • 10
    Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998; 12: 125762.
  • 11
    Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 527.
    Direct Link:
  • 12
    Moayyedi P. Helicobacter pylori Eradication in General Practice: Medical Benefits and Health Economics. Leeds: Institute of Epidemiology and Health Services Research, University of Leeds, 1999.
  • 13
    Office of the Deputy Prime Minister. The English Indices of Deprivation. London: Neighbourhood Renewal Unit, 2004.
  • 14
    Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl 1999; 231: 38.
  • 15
    Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999; 231: 208.
  • 16
    Talley Colin-Jones NJD, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 14560.
  • 17
    Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998; 2: 174.
  • 18
    Management of dyspepsia: report of a working party. Lancet 1988; 1: 5769.
  • 19
    Buckley MJ, Scanlon C, McGurgan P, O'Morain CA. A validated dyspepsia symptom score. Ital J Gastroenterol Hepatol 1997; 29: 495500.
  • 20
    Poitras MR, Verrier P, So C, Paquet S, Bouin M, Poitras P. Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life. Dig Dis Sci 2002; 47: 1297307.
  • 21
    Calvet X, Bustamante E, Montserrat A, et al. Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test. Eur J Gastroenterol Hepatol 2000; 12: 94953.
  • 22
    Dent J. Definitions of reflux disease and its separation from dyspepsia. Gut 2002; 50: 17iv20.
  • 23
    Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45 (Suppl. 2): II3742.
  • 24
    Greatorex R, Thorpe JA. Clinical assessment of gastro-oesophageal reflux by questionnaire. Br J Clin Pract 1983; 37: 1335.
  • 25
    Junghard O, Lauritsen K, Talley NJ, Wiklund IK. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non-ulcer dyspepsia. Eur J Surg Suppl 1998; 583: 10611.
  • 26
    Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 53947.
  • 27
    Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ III. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 145679.
  • 28
    Hu WH, Lam KF, Wong YH, et al. The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia. J Gastroenterol Hepatol 2002; 17: 54551.
  • 29
    Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 6817.
  • 30
    Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther 1998; 12: 106778.
  • 31
    Goldman J, Conrad DF, Ley C, et al. Validation of Spanish language dyspepsia questionnaire. Dig Dis Sci 2002; 47: 62440.
  • 32
    Garratt AM, Ruta DA, Russell I, et al. Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms. J Clin Epidemiol 1996; 49: 56571.
  • 33
    Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995; 82: 21622.
  • 34
    Leidy NK, Farup C, Rentz AM, Ganoczy D, Koch KL. Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI). Dig Dis Sci 2000; 45: 11729.
  • 35
    Rabeneck L, Wristers K, Goldstein JL, Eisen G, Dedhiya SD, Burke TA. Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol 2002; 97: 329.
    Direct Link:
  • 36
    Drossman DA. The functional gastrointestinal disorders and the Rome III Process. Gastroenterology 2006; 130: 137790.
  • 37
    Vakil N, VanZanten S, John D, Kahrilas P, Roger J. The Definition of GERD: a Global, Evidence-based Consensus. Los Angeles, USA: Digestive Disease Week, 2006.
  • 38
    Rabeneck L, Cook KF, Wristers K, Souchek J, Menke T, Wray NP. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol 2001; 54: 75565.
  • 39
    Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci 2001; 46: 15409.
  • 40
    Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998; 93: 140915.
  • 41
    Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798810.
  • 42
    Penston JG. Review article: Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996; 10: 46986.